INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (INFLUENCE)
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands, 1066CX
- The Netherlands Cancer Institute / Antoni van Leeuwenhoek
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Written informed consent, prior to performing any protocol related procedures.
- Age ≥ 18 years at time of study entry.
- ≥ T1 penile or tongue squamous cell cancer
- Scheduled for surgical primary tumour resection
Exclusion Criteria:
- Involvement in the planning and/or conduct of the study.
- Pregnant woman
- Abstaining from usage of two forms of barrier contraceptive or actively planning pregnancy within 90 days.
- Severe kidney insufficiency
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
tumour visualization by means of c-MET targeted fluores-cence imaging
Time Frame: peri-operative
|
The feasibility of intraoperative tumour visualization by means of c-MET targeted fluores-cence imaging will be evaluated, and the imaging result will be correlated to the level of c-MET expression determined using standard immunohistochemistry.
|
peri-operative
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lymph node visualization by means of c-MET targeted fluores-cence imaging
Time Frame: peri-operative
|
Detection and visualization of lymph node metastases in penile and tongue tumour patients
|
peri-operative
|
|
Dysplasia or Cis by means of c-MET targeted fluores-cence imaging
Time Frame: Peri-operative
|
Identification of dysplasia or carcinoma in situ in penile and tongue tumours.
|
Peri-operative
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Baris Karakullukcu, MD, PhD, The Netherlands Cancer Institute
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- N19IFC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.